Ann: Suspension from Official Quotation, page-4

So ive been re-reading the quarterly again. i just wanted to clear it up.
i was mistaken KR only left the Tartana directorship, he is still with us.

but something else stood out.

"The aim of the trial is to establish the mostoptimal way to control chemical dosing to the twenty-four Phoenix dewatering process units on the site. Thechemical sales opportunity remains open and it is expected that an outcome and path forward will becomeevident for both the OptiFlox® technology and the chemical sales opportunity in Q1 2019."

The focus for the current quarter is as follows:• Commercial progress of the OptiFlox® trial at major coking coal operation in the Bowen Basin.


one of 24....


Either way this year looks pretty promising. with a new supply line, trials in Asia in Resource recovery , and advanced stage Iron ore trials. plenty of new releases to happen.
lets just hope the broader market can keep it together for a few more years.